Add like
Add dislike
Add to saved papers

64 CuCl 2 PET/CT in Prostate Cancer Relapse.

Our objective was to evaluate the biodistribution, kinetics, and radiation dosimetry of 64 CuCl2 in humans and to assess the ability of 64 CuCl2 PET/CT to detect prostate cancer (PCa) recurrence in patients with biochemical relapse. Methods: We prospectively evaluated 50 PCa patients with biochemical relapse after surgery or external-beam radiation therapy. All patients underwent 64 CuCl2 PET/CT, 18 F-choline PET/CT, and multiparametric MRI within 15 d of each other. Experienced readers interpreted the images, and the detection rate (DR) of each imaging modality was calculated. Histopathology, when available; clinical or laboratory response; and multidisciplinary follow-up were used to confirm the site of disease. In parallel, biodistribution, kinetics of the lesions, and radiation dosimetry of 64 CuCl2 were evaluated. Results: From a dosimetric point of view, an administered dose of 200 MBq for 64 CuCl2 translated into a 5.7-mSv effective dose. Unlike 18 F-choline, 64 CuCl2 was not excreted or accumulated in the urinary tract, thus allowing thorough pelvic exploration. The maximum 64 CuCl2 uptake at the sites of PCa relapse was observed 1 h after tracer injection. In our cohort, 64 CuCl2 PET/CT proved positive in 41 of 50 patients, with an overall DR of 82%. The DRs of 18 F-choline PET/CT and multiparametric MRI were 56% and 74%, respectively. The difference between the DRs of 64 CuCl2 PET/CT and 18 F-choline PET/CT was statistically significant ( P < 0.001). Interestingly, on considering prostate-specific antigen (PSA) value, 64 CuCl2 PET/CT had a higher DR than 18 F-choline PET/CT in patients with a PSA of less than 1 ng/mL. Conclusion: The biodistribution of 64 CuCl2 is more suitable than that of 18 F-choline for exploring the pelvis and prostatic bed. The 64 CuCl2 effective dose is like those of other established PET tracers. In patients with biochemical relapse and a low PSA level, 64 CuCl2 PET/CT shows a significantly higher DR than 18 F-choline PET/CT.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app